Business Wire

Large Real-World, Multi-Center Study Demonstrates Viz.ai Platform Saves Critical Minutes in Stroke Care

Share

Viz.ai, the leader in AI-powered disease detection and care coordination, and TeleSpecialists LLC, a physician-owned management service organization committed to providing exceptional emergent and non-emergent neurology and psychiatric patient care via telemedicine, announced new data presented today at the International Stroke Conference (ISC) from the VALIDATE (Validation of Artificial intelligence to LImit Delays in Acute stroke Treatment and Endovascular therapy) study. The study demonstrated that hospital utilization of Viz’ AI-powered care coordination platform was associated with a 39.5 minute reduction in patient arrival to time of first contact with the neurointerventionalist for need for potential emergency endovascular treatment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230208005564/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

VALIDATE Study: Median Arrival to Neurointerventionalist Notification Times (Graphic: Business Wire)

“In the world of stroke treatment, the saying ‘time is brain’ comes from the fact that when brain tissue is deprived of oxygenated blood, approximately two million neurons die every minute,” said Theresa Sevilis, DO, director of clinical research at TeleSpecialist and study co-author. “VALIDATE data show that use of the Viz platform resulted in a clinically important decrease in the time it took for large blood vessel occlusion recognition and contact with the interventional team, which in turn may translate to fewer neurons dying and, ultimately, better patient outcomes.”

The independent VALIDATE study analyzed data extracted from acute stroke consultations seen by TeleSpecialists’ neurologists in the emergency department across 166 facilities in 17 states. A total of 14,116 patients were included from two groups: those seen in hospitals using AI (n=8,557) and those seen in hospitals not using AI (n=5,559). The study found that the median door to neurointerventionalist notification time for AI was 50 minutes compared to the median door to neurointerventionalist notification time for non-AI at 89.5 minutes (p <0.001), a difference of 39.5 minutes. Importantly, the statistically significant (p<0.01) improvement in time to large clot recognition and contact with the neurointerventional team at Viz-enabled centers occurred regardless of whether the center did or did not have thrombectomy-capability.

"These data, which resulted from measuring the impact of our platform on patient care in the real world, reinforce results we’ve seen in previous studies that have typically involved a single center with a limited number of patients,” said Jayme Strauss, chief clinical officer, Viz.ai. “The first multi-center study involving a large number of patients, VALIDATE compared results from the same time period between hospitals that used the Viz.ai platform and those that did not have AI software, thus eliminating the potential confounding effect of changes in workflow that occur in hospitals over time. This tightly controlled scientific study clearly illustrates the tremendous impact of our technology.”

“The VALIDATE results demonstrate a time improvement in emergency stroke workflow between Viz-enabled and non-Viz-enabled centers that was statistically significant and highly clinically important,” said Thomas Devlin, MD, PhD, Professor of Neurology at the University of Tennessee Health Science Center, and co-author of the study. “The study design allowed for very careful and rigorous insight into exactly how powerful the Viz.ai platform is at expediting treatment for one of the most time-sensitive conditions in all of medicine.”

Viz.ai and TeleSpecialists announced a strategic partnership last year aimed at bringing AI-powered care coordination together with leading telestroke neurologists to optimize time to treatment and improve patient outcomes across the United States.

For more information on the study results, visit the ISC website.

About Viz.ai, Inc.

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 200 million lives across 1,300+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a particular disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by clinical evidence, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

About TeleSpecialists, LLC

TeleSpecialists is a leading national physician-owned provider of telemedicine solutions for quality-focused hospitals and healthcare systems that sets the standard for rapidly accessible remote neurology and psychiatry services, both emergent and non-emergent.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Ariane Lovell
ariane.lovell@finnpartners.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Campbell Lutyens and J.P. Morgan announce strategic collaboration in the secondary advisory market21.3.2023 14:30:00 EET | Press release

Campbell Lutyens and J.P. Morgan are pleased to announce the establishment of a strategic collaboration to jointly offer their advisory services on single-asset and concentrated multi-asset continuation fund secondary transactions. The offering will enable clients to benefit from Campbell Lutyens’ and J.P. Morgan’s global, market leading secondary and Investment banking advisory practices, respectively. The proposition combines J.P. Morgan’s global top-tier investment banking services with Campbell Lutyens’ leading global placement and secondary advisory platform, creating a best-in-class global offering for single-asset and concentrated multi-asset continuation funds. It will be available for clients across all regions and sectors in which Campbell Lutyens and J.P. Morgan both operate. The offering provides access to Campbell Lutyens’ secondaries expertise focused on fund structuring and capital raising from secondaries and institutional investors along with J.P. Morgan’s M&A services

KBI Biopharma, Inc. Releases Inaugural FIH Manufacturing Batch at Integrated Switzerland Facility Five Months After Opening21.3.2023 14:30:00 EET | Press release

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced that late in 2022, it successfully released its inaugural First In Human (FIH) manufacturing batch in compliance with current Good Manufacturing Practice (cGMP) standards in its recently expanded Geneva mammalian cell manufacturing facility. The swift execution of this important milestone demonstrates the capabilities in cell line development (CLD) and biologics manufacturing of KBI and Selexis, allowing clients to accelerate clinical research timelines. In July 2022, KBI and Selexis announced the completion of the fully integrated, 8,733 square-meter site combining Selexis’ Cell Line Development services and KBI’s development and manufacturing services. This milestone comes only five months after starting operations at the combined facility. “Delivering this first batch affirms KBI’s commitment to helping pharmaceutical and biotechnology companies across the world achieve their manufacturing goals,” said Mike Land

Visa Defines New Era of How Money Travels Abroad21.3.2023 14:00:00 EET | Press release

Remittances are not only a lifeline for millions of migrant workers and their families, they are also vitally important for the prosperity of many developing economies around the world. As the amount of global remittance inflows continues to reach new records1, 53% of surveyed consumers are turning to digital apps to send and receive funds around the world. Visa today unveiled its “Money Travels: 2023 Digital Remittances Adoption” research report, a survey of over 14,000 consumers across ten countries, revealing that digital remittances are quickly becoming the most popular way to move money internationally, when compared to going to a physical bank or branch (34%); sending cash, checks or money orders by mail (12%); or giving money to another person who is traveling to their home country (11%). In conjunction with the study, Visa launched “Money Travels,” a new podcast series unearthing how payment-related topics unfold differently in various places around the world and highlighting t

Hansen Powers Intraday Trading for Skellefteå Kraft21.3.2023 12:00:00 EET | Press release

Hansen Technologies (ASX:HSN), a leading global provider of software and services to the energy, water and communications industries, is pleased to announce a new agreement with Skellefteå Kraft, an energy company operating in Sweden. As part of the agreement, Skellefteå Kraft, will use Hansen Trade for automated intraday trading operations. The intraday trading solution within Hansen Trade will enable Skellefteå Kraft to automate intraday trading operations and reach significant cost savings in balance management. Skellefteå Kraft will thus be able to automate intraday trading operations with a modern and easy-to-use trading solution – thereby allowing the company to produce beneficial outcomes and implement zero-touch automation. This in turn will replace costly, manual interventions, and minimise risks in the real-time intraday market. Stefan Forsgren, Business Area Director, Power System at Skellefteå Kraft commented: “In the current volatile climate, which also encompasses the rap

REPLY: Comwrap Reply Named Adobe 2023 Digital Experience Emerging Partner of the Year - Central Europe21.3.2023 11:30:00 EET | Press release

Comwrap Reply, the Reply Group company that specialises in cloud-native digital experience services has been awarded the prestigious Adobe 2023 Digital Experience Emerging Partner of the Year - Central Europe. The award honours companies that have made leading contributions to Adobe’s business and significantly impacted customer success. This award is the result of a strategic roadmap that started with Adobe in 2008 to provide high-value solutions to customers and organisations throughout the world. This announcement comes after Reply acquired multiple Adobe Specializations in recent years and was named a Platinum Solution Partner in 2022. “Comwrap Reply demonstrated strong collaboration with Adobe Customer Solutions by delivering cloud-native client implementations. They have proven their continued dedication toward growing their Adobe Experience Platform practice in Europe, which contributed significantly to earning this award. We look forward to continuing our strategic partnership

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom